United Kingdom · Question · Written question
UIN 3157
Teva: Parkinson's Disease
Original
Introduced
30 August 2024
Last action
9 September 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
9 September 2024
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of medication for Parkinson's disease produced by Teva Pharmaceuticals.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
30 August 2024
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of medication for Parkinson's disease produced by Teva Pharmaceuticals.
Source: Commons
9 September 2024
Answer
Teva Pharmaceuticals supply a range of medicines to treat Parkinson’s disease. We are not aware of any issues with Teva Pharmaceuticals’ supply of these medicines. Teva Pharmaceuticals discontinued amantadine 100 milligram capsules in July 2024, however a...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-08-30/3157
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1725974
- uk · wq-1725974 · source updated 9 September 2024